Surgery Partners, Inc. (SGRY)
- Previous Close
32.26 - Open
32.79 - Bid 32.44 x 100
- Ask 32.51 x 100
- Day's Range
32.41 - 33.21 - 52 Week Range
22.05 - 36.92 - Volume
203,222 - Avg. Volume
1,093,230 - Market Cap (intraday)
4.132B - Beta (5Y Monthly) 2.76
- PE Ratio (TTM)
-- - EPS (TTM)
-0.26 - Earnings Date Nov 5, 2024 - Nov 11, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
39.33
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers diagnostic imaging, laboratory, obstetrics, oncology, pharmacy, physical therapy, and wound care; and ancillary services, including multi-specialty physician practices, urgent care facilities, and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
www.surgerypartners.com10,500
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SGRY
View MorePerformance Overview: SGRY
Trailing total returns as of 9/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SGRY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SGRY
View MoreValuation Measures
Market Cap
4.10B
Enterprise Value
7.32B
Trailing P/E
2.69k
Forward P/E
24.27
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.41
Price/Book (mrq)
2.10
Enterprise Value/Revenue
2.53
Enterprise Value/EBITDA
15.46
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.17%
Return on Assets (ttm)
3.96%
Return on Equity (ttm)
3.73%
Revenue (ttm)
2.89B
Net Income Avi to Common (ttm)
-33.8M
Diluted EPS (ttm)
-0.26
Balance Sheet and Cash Flow
Total Cash (mrq)
253.7M
Total Debt/Equity (mrq)
95.16%
Levered Free Cash Flow (ttm)
163.25M